000 | 01940 a2200565 4500 | ||
---|---|---|---|
005 | 20250515231740.0 | ||
264 | 0 | _c20100727 | |
008 | 201007s 0 0 eng d | ||
022 | _a1879-1891 | ||
024 | 7 |
_a10.1016/j.ajo.2010.02.008 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aGomi, Fumi | |
245 | 0 | 0 |
_aEfficacy of intravitreal bevacizumab combined with photodynamic therapy for polypoidal choroidal vasculopathy. _h[electronic resource] |
260 |
_bAmerican journal of ophthalmology _cJul 2010 |
||
300 |
_a48-54.e1 p. _bdigital |
||
500 | _aPublication Type: Comparative Study; Journal Article | ||
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aAged, 80 and over |
650 | 0 | 4 |
_aAngiogenesis Inhibitors _xtherapeutic use |
650 | 0 | 4 |
_aAntibodies, Monoclonal _xtherapeutic use |
650 | 0 | 4 | _aAntibodies, Monoclonal, Humanized |
650 | 0 | 4 | _aBevacizumab |
650 | 0 | 4 |
_aChoroid _xblood supply |
650 | 0 | 4 |
_aChoroid Diseases _xdiagnosis |
650 | 0 | 4 | _aColoring Agents |
650 | 0 | 4 | _aCombined Modality Therapy |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aFluorescein Angiography |
650 | 0 | 4 | _aFollow-Up Studies |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aIndocyanine Green |
650 | 0 | 4 | _aInjections |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aPeripheral Vascular Diseases _xdiagnosis |
650 | 0 | 4 | _aPhotochemotherapy |
650 | 0 | 4 | _aRetrospective Studies |
650 | 0 | 4 | _aTomography, Optical Coherence |
650 | 0 | 4 | _aTreatment Outcome |
650 | 0 | 4 |
_aVascular Endothelial Growth Factor A _xantagonists & inhibitors |
650 | 0 | 4 |
_aVisual Acuity _xphysiology |
650 | 0 | 4 | _aVitreous Body |
700 | 1 | _aSawa, Miki | |
700 | 1 | _aWakabayashi, Taku | |
700 | 1 | _aSasamoto, Yuzuru | |
700 | 1 | _aSuzuki, Mihoko | |
700 | 1 | _aTsujikawa, Motokazu | |
773 | 0 |
_tAmerican journal of ophthalmology _gvol. 150 _gno. 1 _gp. 48-54.e1 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.ajo.2010.02.008 _zAvailable from publisher's website |
999 |
_c19955938 _d19955938 |